Ignite Creation Date:
2025-12-24 @ 3:26 PM
Ignite Modification Date:
2026-02-20 @ 1:44 PM
Study NCT ID:
NCT02588092
Status:
TERMINATED
Last Update Posted:
2020-02-26
First Post:
2015-08-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)
Sponsor:
ADC Therapeutics S.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ADCT-301-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None